The U.S. Department of Defense is supporting creation of a small, portable device that safely sends vaccines and therapies through the skin. The device is being developed by Inovio Pharmaceuticals Inc. in Plymouth Meeting, Pennsylvania, and funded by an $8.14 million award from DoD’s Medical CBRN Defense Consortium; CBRN stands for Chemical, Biological, Radiological, and Nuclear threats. Continue Reading
Under Construction 1618 hours 2020 09 26 Continue Reading
Under Construction 1607 hours 2020 09 26 Continue Reading
Under Construction 1556 hours 2020 09 26 Continue Reading
Until now, local inflammation and scar tissue from the so-called “foreign body response” has prevented the development of in-body sensors capable of continuous, long-term monitoring of body chemistry. But today scientists are presenting results showing tiny biosensors that become one with the body have overcome this barrier, and stream data to a mobile phone and to the cloud for personal and medical use. Continue Reading
Broadly defined, transfection is the process of artificially introducing nucleic acids (DNA or RNA) into cells, utilizing means other than viral infection. Such introductions of foreign nucleic acid using various chemical, biological, or physical methods can result in a change of the properties of the cell, allowing the study of gene function and protein expression in the context of the cell. Continue Reading
Under Construction 0703 hours 2020 09 26 Continue Reading
Under Construction 0653 hours 2020 09 26 Continue Reading
Under Construction 2235 hours 2020 09 25 Continue Reading
Under Construction 2230 hours 2020 09 25 Continue Reading